Viratech Corp (VIRA) 0.0045 $VIRA
BUYINS.NET Issues Viratech Corp. SqueezeTrigger Report
GlobeNewswire - Tue Jul 16, 7:30AM CDT
-- Approximately 600,187 Shares Shorted Since May 2013
Viratech Corp. Publishes e-Book on Open Source Biotech Research
Marketwire - Wed Feb 27, 8:02AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has published its e-Book on open source biotech research. The book, "Open Source Cancer Research," by Dr. Kevin Buckman, describes how the first open source biotech research social network platform works to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. The book can be purchased at: http://www.amazon.com/Open-Source-Cancer-Rese...B00BL8N3TA.
Viratech and Diabetes.net Sign Agreement
Marketwire - Thu Feb 21, 8:01AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turn-key Social Network for Diabetes Network Charities at http//diabetes.net, for $250,000, plus 25% royalty from all revenue derived from the operation of the site.
Viratech Corp. Launches Cancer.im Cancer Patient Support Social Network
Marketwire - Mon Feb 18, 11:01PM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the launch of Cancer.im, http://cancer.im, a social network resource site for cancer patients, survivors, advocates, and volunteers. Cancer.im harnesses social collaboration utilities to develop what Viratech believes will become the first experience-based search engine powered by social collaboration http://www.youtube.com/watch?v=dz1tHRb3wvU.
Harbinger Issues Special Situation Report on Viratech Corp.
Marketwire - Mon Jan 28, 8:02AM CST
Harbinger Research is pleased to announce the issuance of a Special Situations report pertaining to Viratech Corporation, (PINKSHEETS: VIRA). http://www.harbingerresearch.com/clients/vira
Breast Cancer Book Achieves Number 1 Best Seller Status on Amazon.com
Marketwire - Sun Jan 27, 4:51PM CST
Viratech Corp. (PINKSHEETS: VIRA) announced today that Cancer.im's first of 235 books to be released on Amazon's Kindle platform, focusing on Cancer, Find and Stop Breast Cancer, by Dr. Kevin Buckman, has achieved number 1 best-seller status for both Breast Cancer and Oncology categories. The book can be bought here: http://www.amazon.com/Find-Stop-Breast-Cancer...ast+cancer
Cancer.im Announces Breast Cancer Book Released via Amazon's Kindle Platform
Marketwire - Thu Jan 24, 9:41AM CST
Viratech Corp. (PINKSHEETS: VIRA) announced today that Cancer.im, http://www.Cancer.im, designed to be the world's first experience based social network resource site for people affected by cancer, has released the first of 235 books to be released on Amazon's Kindle platform, focusing on Cancer.
Viratech Signs Letter of Intent to Provide Social Network for $250,000, Royalties and Equity Interest
Marketwire - Fri Jan 18, 8:00AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turnkey Social Network for Wellness Builder, Inc., a company engaged in the development of a series of nutraceutical products designed to combat the effects of stress, inadequate nutrition and exposure to environmental toxins.
Dr. Mort Rothbard Joins Viratech Advisory Board
Marketwire - Tue Jan 08, 9:38AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the addition of Mort Rothbard MD to its Advisory Board.
Viratech Announces Acquisition of Cancer.im for $6.2 Million in Securities
Marketwire - Thu Dec 20, 5:58AM CST
Viratech Corp. (PINKSHEETS: VIRA) http://viratech.org, the first open source biotech research social network platform, announced today an acquisition merger with Cancer.im, Inc., in exchange for $6.2 million in Viratech restricted common stock.
BUYINS.NET Issues Viratech Corp. SqueezeTrigger Report
GlobeNewswire - Tue Jul 16, 7:30AM CDT
-- Approximately 600,187 Shares Shorted Since May 2013
Viratech Corp. Publishes e-Book on Open Source Biotech Research
Marketwire - Wed Feb 27, 8:02AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has published its e-Book on open source biotech research. The book, "Open Source Cancer Research," by Dr. Kevin Buckman, describes how the first open source biotech research social network platform works to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. The book can be purchased at: http://www.amazon.com/Open-Source-Cancer-Rese...B00BL8N3TA.
Viratech and Diabetes.net Sign Agreement
Marketwire - Thu Feb 21, 8:01AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turn-key Social Network for Diabetes Network Charities at http//diabetes.net, for $250,000, plus 25% royalty from all revenue derived from the operation of the site.
Viratech Corp. Launches Cancer.im Cancer Patient Support Social Network
Marketwire - Mon Feb 18, 11:01PM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the launch of Cancer.im, http://cancer.im, a social network resource site for cancer patients, survivors, advocates, and volunteers. Cancer.im harnesses social collaboration utilities to develop what Viratech believes will become the first experience-based search engine powered by social collaboration http://www.youtube.com/watch?v=dz1tHRb3wvU.
Harbinger Issues Special Situation Report on Viratech Corp.
Marketwire - Mon Jan 28, 8:02AM CST
Harbinger Research is pleased to announce the issuance of a Special Situations report pertaining to Viratech Corporation, (PINKSHEETS: VIRA). http://www.harbingerresearch.com/clients/vira
Breast Cancer Book Achieves Number 1 Best Seller Status on Amazon.com
Marketwire - Sun Jan 27, 4:51PM CST
Viratech Corp. (PINKSHEETS: VIRA) announced today that Cancer.im's first of 235 books to be released on Amazon's Kindle platform, focusing on Cancer, Find and Stop Breast Cancer, by Dr. Kevin Buckman, has achieved number 1 best-seller status for both Breast Cancer and Oncology categories. The book can be bought here: http://www.amazon.com/Find-Stop-Breast-Cancer...ast+cancer
Cancer.im Announces Breast Cancer Book Released via Amazon's Kindle Platform
Marketwire - Thu Jan 24, 9:41AM CST
Viratech Corp. (PINKSHEETS: VIRA) announced today that Cancer.im, http://www.Cancer.im, designed to be the world's first experience based social network resource site for people affected by cancer, has released the first of 235 books to be released on Amazon's Kindle platform, focusing on Cancer.
Viratech Signs Letter of Intent to Provide Social Network for $250,000, Royalties and Equity Interest
Marketwire - Fri Jan 18, 8:00AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turnkey Social Network for Wellness Builder, Inc., a company engaged in the development of a series of nutraceutical products designed to combat the effects of stress, inadequate nutrition and exposure to environmental toxins.
Dr. Mort Rothbard Joins Viratech Advisory Board
Marketwire - Tue Jan 08, 9:38AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the addition of Mort Rothbard MD to its Advisory Board.
Viratech Announces Acquisition of Cancer.im for $6.2 Million in Securities
Marketwire - Thu Dec 20, 5:58AM CST
Viratech Corp. (PINKSHEETS: VIRA) http://viratech.org, the first open source biotech research social network platform, announced today an acquisition merger with Cancer.im, Inc., in exchange for $6.2 million in Viratech restricted common stock.
